Bristagen
Brand names,
Bristagen
Analogs
Bristagen
Brand Names Mixture
- Diprogen Crm (Betamethasone Dipropionate + Gentamicin Sulfate)
- Diprogen Ont (Betamethasone Dipropionate + Gentamicin Sulfate)
- Garasone Oph/Ot Sol (Betamethasone + Gentamicin Sulfate)
- Garasone Ophthalmic Ointment (Betamethasone + Gentamicin Sulfate)
- Gentamicin Sulfate in Nacl 0.9% Inj (Gentamicin Sulfate + Sodium Chloride)
- Gentamicin Sulfate in Nacl 0.9% Inj (Gentamicin Sulfate + Sodium Chloride)
- Gentocin Durafilm (Betamethasone 21-Acetate + Gentamicin Sulfate)
- Gentocin Otic Solution (Betamethasone + Gentamicin Sulfate)
- Otomax Ointment (Betamethasone + Clotrimazole + Gentamicin Sulfate)
- Sandoz Pentasone (Betamethasone + Gentamicin Sulfate)
- Topagen Ont (Betamethasone + Gentamicin Sulfate)
- Topagen Spray (Betamethasone + Gentamicin Sulfate)
- Valisone G Cream (Betamethasone + Gentamicin Sulfate)
- Valisone G Ointment (Betamethasone + Gentamicin Sulfate)
Bristagen
Chemical_Formula
C21H43N5O7
Bristagen
RX_link
http://www.rxlist.com/cgi/generic2/pedgenta.htm
Bristagen
fda sheet
Bristagen
msds (material safety sheet)
Bristagen
Synthesis Reference
No information avaliable
Bristagen
Molecular Weight
477.596 g/mol
Bristagen
Melting Point
105°C (218-237°C as sulfate salt)
Bristagen
H2O Solubility
100 mg/mL
Bristagen
State
Solid
Bristagen
LogP
-3.637
Bristagen
Dosage Forms
Cream; Drops; Liquid; Ointment; Solution
Bristagen
Indication
For treatment of serious infections caused by susceptible strains of the following microorganisms: P. aeruginosa, Proteus species (indole-positive and indole-negative), E. coli, Klebsiella-Enterobactor-Serratia species, Citrobacter species and Staphylococcus species (coagulase-positive and coagulase-negative).
Bristagen
Pharmacology
Gentamicin is a broad spectrum aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.
Bristagen
Absorption
Injections lead to peak serum concentrations in 30-60 minutes. Topical gentamicin is readily absorbed from large burned, denuded, or granulating areas but not through intact skin. Absorption of gentamicin is faster and greater with the cream compared to the ointment. Gentamicin is absorbed in small quantities following topical application to the eye. Gentamicin is also absorbed in small amounts following topical application to the ear (especially if the eardrum is perforated or if tissue damage is present).
Bristagen
side effects and Toxicity
Mouse, intravenous LD50: 52 mg/kg; rat, intravenous LD50: 96 mg/kg.
Bristagen
Patient Information
No information avaliable
Bristagen
Organisms Affected
Enteric bacteria and other eubacteria